Form 4 for CELU Celularity Inc
Accepted 2022-07-15 00:00:00 ET · period of report 2022-07-13 · accession 0000899243-22-026184 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-15 | 2022-07-13 | CELU | VON ESCHENBACH ANDREW C. | Dir | A - Grant | $0.00 | +36.1K | 136.1K | +36% | $0 |
| D | 2022-07-15 | 2022-07-13 | CELU | VON ESCHENBACH ANDREW C. | Dir | A - Grant | $0.00 | +54.2K | 54.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-07-13 | A | A | 36,145 | $0.00 | 136,145 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-07-13 | A | A | 54,152 | $0.00 | 54,152 | D | $4.15 · — to 2032-07-13 | 54,152 Class A Common Stock | (F2) This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. |